Skip to content

Opening book details…

Can I read 1635. Oral Delivery of Amikacin-Lipid NanoCrystal Formulations Safely and Effectively Treat Macrolide Resistant Mycobacteria Infections in a Mouse Model of Cystic Fibrosis on EtoBox?

1635. Oral Delivery of Amikacin-Lipid NanoCrystal Formulations Safely and Effectively Treat Macrolide Resistant Mycobacteria Infections in a Mouse Model of Cystic Fibrosis by Ruying Lu; Raphael J Mannino; Diane J Ordway is a Medicine article available to read on EtoBox.

What is 1635. Oral Delivery of Amikacin-Lipid NanoCrystal Formulations Safely and Effectively Treat Macrolide Resistant Mycobacteria Infections in a Mouse Model of Cystic Fibrosis about?

## Abstract ## Background In the cystic fibrosis lung, infections by intracellular pathogens, such as Mycobacteria, are problematic to treat due to a thick buildup of mucous as well as the difficulty of many anti-microbial agents, such as amikacin, to penetrate across the plasma membranes of infected cells. Lipid NanoCrystals (LNCs), mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance targeting to mycobacterial infected cells followed by intracellular drug delivery. ## Methods The oral efficacy of Amikacin-LNC (AmK-LNC) was evaluated in the cystic fibrosis (B6CFTR^tm1UNC^/CFTR^tm1UNC^) chronic mouse model against each of the three NTM strains having high resistance to macrolide antibiotics (__M. avium subsp intracellulare__ 25292__, M. abscesus ssp abscessus__ 1513, and __M. abscessus ssp bolletii__ 1948). Mice were infected with a pulmonary aerosol of 1x10^8^ CFUs of the macrolide resistant strain and treated daily starting on day 28 for a total of 8 weeks with saline control, oral LP-4 CAmK Lyophilized 50 mg/kg BID, oral LP-4 CAMK Lyophilized 100 mg/kg BID, IP Amikacin (AMI) 150 mg/kg QD, or oral Clarithromycin 250 mg/kg QD. Bacterial bur

Who reads 1635. Oral Delivery of Amikacin-Lipid NanoCrystal Formulations Safely and Effectively Treat Macrolide Resistant Mycobacteria Infections in a Mouse Model of Cystic Fibrosis?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ruying Lu; Raphael J Mannino; Diane J Ordway
Publisher
Oxford University Press (OUP)
Published
2020
Language
EN
Field
Medicine (Health Sciences)

More by Ruying Lu; Raphael J Mannino; Diane J Ordway

Browse all works by Ruying Lu; Raphael J Mannino; Diane J Ordway